Abstract

Paliperidone Tablets Approved for Treatment of Schizophrenia in Adolescents

Author(s): Peter F. Buckley

Paliperidone extended release tablet formulation has recently been approved by the U.S. Food and Drug Administration (FDA) for use in adolescents (aged 12–17 years) with schizophrenia.

• PDF